Provided by Tiger Fintech (Singapore) Pte. Ltd.

Jazz Pharmaceuticals PLC

110.80
+1.821.67%
Pre-market: 109.85-0.9500-0.86%04:41 EDT
Volume:896.34K
Turnover:98.83M
Market Cap:6.73B
PE:12.81
High:111.17
Open:108.52
Low:107.66
Close:108.98
Loading ...

Jazz Pharmaceuticals Receives Positive EMA Panel Opinion for Zanidatamab to Treat Biliary Tract Cancer

MT Newswires Live
·
26 Apr

Jazz Pharmaceuticals Receives CHMP Positive Opinion for Zanidatamab for the Treatment of Advanced HER2-Positive Biliary Tract Cancer

PR Newswire
·
25 Apr

Rpt-Ema Says Chmp Recommended Granting Conditional Marketing Authorisation for Ziihera (Zanidatamab)

THOMSON REUTERS
·
25 Apr

BRIEF-EMA Says Tepezza Received Positive CHMP Opinion For Treatment Of Adults With Moderate To Severe Thyroid Eye Disease

Reuters
·
25 Apr

Rpt-Ema Says Sephience (Sepiapterin) Got Positive Opinion From Chmp for Treatment of Hyperphenylalaninaemia in Adults & Children With Phenylketonuria

THOMSON REUTERS
·
25 Apr

Corrected-Ema Says Chmp Will Re-Examine (Not 'Requested Re-Examination of') Opinion Adopted for Marketing Authorisation Holder for Kisunla (Donanemab)

THOMSON REUTERS
·
25 Apr

Rpt-Ema Says Chmp Recommends Conditional Marketing Authorisation for Duvyzat (Givinostat), as Treatment for Dmd in Patients From Age Six Who Can Walk

THOMSON REUTERS
·
25 Apr

Ema Says Chmp Recommended Granting Conditional Marketing Authorisation for Ziihera (Zanidatamab)

THOMSON REUTERS
·
25 Apr

Top Analyst Reports for Coca-Cola, Abbott & RTX

Zacks
·
24 Apr

Jazz Pharmaceuticals Showcases Transformative Data at Asco 2025, Highlighting Advances in Small Cell Lung Cancer, Her2+ Gastroesophageal Cancer and Diffuse Glioma

THOMSON REUTERS
·
24 Apr

Jazz Pharmaceuticals Showcases Transformative Data at ASCO 2025, Highlighting Advances in Small Cell Lung Cancer, HER2+ Gastroesophageal Cancer and Diffuse Glioma

PR Newswire
·
24 Apr

Buy 5 High ROE Stocks as Markets Break Tariff-Induced Losing Streak

Zacks
·
23 Apr

3 Small-Cap Stocks in the Doghouse

StockStory
·
23 Apr

Jazz Pharmaceuticals to Report First Quarter Financial Results on May 6, 2025

THOMSON REUTERS
·
23 Apr

Jazz Pharmaceuticals to Report First Quarter Financial Results on May 6, 2025

PR Newswire
·
23 Apr

Jazz Pharmaceuticals Completes Acquisition of Chimerix

THOMSON REUTERS
·
22 Apr

Jazz Pharmaceuticals Completes Acquisition of Chimerix

PR Newswire
·
22 Apr

Sanofi & Regeneron's Dupixent Receives FDA Nod for Urticaria

Zacks
·
21 Apr

JAZZ vs. HRMY: Which Neuroscience Drugmaker Is the Stronger Play?

Zacks
·
21 Apr

Why Jazz Pharmaceuticals (JAZZ) is a Top Value Stock for the Long-Term

Zacks
·
17 Apr